NCT01135199View on ClinicalTrials.gov

Pomalidomide for Cough in Patients With Idiopathic Pulmonary Fibrosis

PHASE2WithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 30, 2010

Primary Completion Date

June 30, 2010

Study Completion Date

June 30, 2010

Conditions
Pulmonary Fibrosis
Interventions
DRUG

pomalidomide (CC-4047

Trial Locations (1)

94305

Stanford University School of Medicine, Stanford

Sponsors

Collaborators (1)

Celgene Corporation
All Listed Sponsors
collaborator

Celgene Corporation

INDUSTRY

lead

Stanford University

OTHER

NCT01135199 - Pomalidomide for Cough in Patients With Idiopathic Pulmonary Fibrosis | Biotech Hunter | Biotech Hunter